Evidence map›Paper›PMID 39669595›Full record

ArticleGenetics in medicine open2024

Non-RB1 germline cancer predisposing variants found in retinoblastoma patients.

Ana Maria Rodriguez Barreto, Michael F Walsh, Melissa A Robbins, Audrey Mauguen, Elise M Fiala, Cristina Olcese, Dianna Haggag-Lindgren, Diana Mandelker, Jasmine H Francis, Michael F Berger and 3 more

Abstract read
In one paragraph

Article in Genetics in medicine open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ana Maria Rodriguez BarretoDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Michael F WalshDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Melissa A RobbinsDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
Audrey MauguenDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Elise M FialaDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Cristina OlceseDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
Dianna Haggag-LindgrenDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Diana MandelkerDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Jasmine H FrancisDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Michael F BergerDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
Danielle Novetsky FriedmanDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Kenneth OffitDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
David H AbramsonDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Purpose: It is well known that individuals with hereditary retinoblastoma are at lifelong high risk for developing subsequent malignant neoplasms (SMN). However, the role that non- Methods: Retrospective data collection from institutional electronic medical records of 94 individuals seen at our institution with personal history of retinoblastoma, who had undergone next-generation sequencing germline analysis. Results: The prevalence of individuals with cancer predisposition was 57% (54/94). Of these individuals, 76% (41/54) had a pathogenic/likely pathogenic (P/LP) variant only in the Conclusion: In this small cohort of patients with retinoblastoma, non-

Indexed as

CancerGeneticsGermline cancer susceptibility syndromesRetinoblastomaSecondary malignancies

Identifiers

PMID39669595
PMCPMC11613778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.